Literature DB >> 29346161

Promotion of Exercise in Multiple Sclerosis Through Health Care Providers.

Robert W Motl, Elizabeth A Barstow, Sarah Blaylock, Emma Richardson, Yvonne C Learmonth, Matthew Fifolt.   

Abstract

Participation in exercise yields meaningful benefits among persons with multiple sclerosis (MS), yet this population engages in low rates of health-promoting physical activity. The disconnect between evidence of benefits and rates of participation requires consideration of new opportunities for changing this health behavior. The current article hypothesizes that the patient-provider interaction offers a fertile opportunity for promoting exercise behavior in MS.

Entities:  

Mesh:

Year:  2018        PMID: 29346161     DOI: 10.1249/JES.0000000000000140

Source DB:  PubMed          Journal:  Exerc Sport Sci Rev        ISSN: 0091-6331            Impact factor:   6.230


  4 in total

1.  Exercise Training Guidelines for Multiple Sclerosis, Stroke, and Parkinson Disease: Rapid Review and Synthesis.

Authors:  Yumi Kim; Byron Lai; Tapan Mehta; Mohanraj Thirumalai; Sangeetha Padalabalanarayanan; James H Rimmer; Robert W Motl
Journal:  Am J Phys Med Rehabil       Date:  2019-07       Impact factor: 2.159

2.  Addressing Physical Activity Behavior in Multiple Sclerosis Management: A Qualitative Account of Health Care Providers' Current Practices and Perspectives.

Authors:  Sarah J Donkers; Sarah Oosman; Stephan Milosavljevic; Kristin E Musselman
Journal:  Int J MS Care       Date:  2019-11-18

3.  Do internet resources align with exercise training and physical activity guidelines for people with multiple sclerosis?

Authors:  Dena Sadeghi-Bahmani; Stephanie L Silveira; Jessica F Baird; Robert W Motl
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-09-30

Review 4.  Exercise Training for Multiple Sclerosis: A Narrative Review of History, Benefits, Safety, Guidelines, and Promotion.

Authors:  Yvonne Charlotte Learmonth; Robert Wayne Motl
Journal:  Int J Environ Res Public Health       Date:  2021-12-16       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.